Marianna Valzano

[Marianna Valzano @MariValzano]

#FlorenceConsensus26 begins!

The 2nd International multidisciplinary consensus on integrating radiotherapy with new systemic treatments is now underway.

https://t.co/AuXV3CtIW3

[Marianna Valzano @MariValzano]

#FlorenceOncology26 |
#ADCs in breast cancer
A brilliant overview by Prof. Hope Rugo on the rapidly expanding ADC landscape. The challenge is to integrate to offer the best therapeutic strategies for our patients.
#BreastCancer #PrecisionOncology

[Marianna Valzano @MariValzano]

#FlorenceOncology26 | #TNBC
Residual disease is not just pathology—it is biology.
The challenge: who needs post-neoadjuvant escalation, and with which strategy?
#BreastCancer #PrecisionOncology

[Marianna Valzano @MariValzano]

#FlorenceOncology26 Let’s begin!

Treatment integration and innovative therapeutic strategies will shape the future of oncology.

[OncoAlert @OncoAlert]

A Great start to #FlorenceOncology26 🇮🇹 with WARMING UP: Exploring New Treatment Strategies and future Advances in Oncology!!

Hope you are here to join us in Florence Italy to experience firsthand some great presentations and discussions in #BreastCancer , #ProstateCancer , #HeanandNeckCancer nd so much more!!

If you could not be here, dont worry, your OncoAlert Network has you covered
As Always, by colleagues...for colleagues

@Icro_Meattini, @PierluigiBonomo, @GiulioFrancoli1, @PBlanchardMD, @piet_ost, @AlbigesL, @fizazi_karim, @ChadTangMD, @EdeAzambuja, @delmastro_lucia, @curijoey, @hoperugo, @BarbaraPistill2 , @E_de_Azambuja @ESTRO_RT @AiroBreast

[Icro Meattini @Icro_Meattini]

Pink October 2026: Advancing #breastcancer research, together

#OncoAlert @OncoAlert @EORTC_BCG @EORTC

https://t.co/9hK2bygp2f

[Icro Meattini @Icro_Meattini]

Philip Poortmans and Orit Kaidar Person presented the @EORTC 22922 IMN trial update and state of the art, including precious data on pN0 population

The importance of collecting very long-term data from phase 3 trials @EORTC_BCG

@OncoAlert #OncoAlert

[EORTC @EORTC]

At today’s #WorldCancerResearchDay event, Denis Lacombe, CEO of EORTC:

"World Cancer Research Day reminds us that better cancer care is not always about more treatment, but about the right treatment for the right patient, supported by strong academic cancer research."

[Icro Meattini @Icro_Meattini]

Immune response and immune therapy in breast cancer session @EORTC_BCG

Inspirational academic lectures led by amazing prof Bianchini, Buisseret, and De Caluwé

#BreastCancer

@EORTC @OncoAlert #OncoAlert

[OncoAlert @OncoAlert]

Dear Colleagues, Join @OncoAlert 🚨 LIVE in FLORENCE Italy Oct 9–10, for the 2nd International Multidisciplinary Consensus on Integrating Radiation Therapy with New Systemic Treatments (endorsed by ESTRO)

THERE ARE ONLY 1️⃣ 5️⃣ SPOTS LEFTfor FREE Registration (First Come First Serve) REGISTER HERE 👉 https://t.co/E49Lqkp65W

JOIN US and Top experts building evidence-based recommendations across breast, head & neck, and genitourinary cancers!

[Ilana Schlam @IlanaSchlam]

With 6 FDA approvals in breast cancer already in 2026, it was time to update the breast cancer treatment algorithms. It's a great problem to have when innovation is moving so fast that it's hard to keep up #bcsm @OncoAlert @DFCI_BreastOnc

[Icro Meattini @Icro_Meattini]

LIVE in #FLORENCE 🇮🇹 Oct 9–10
the 2nd International Multidisciplinary Consensus on Integrating #RadiationTherapy with New Systemic Treatments endorsed by @ESTRO

@OncoAlert @AIOMtweet @FondazioneMen

REGISTER HERE 👉 https://t.co/Wwk8EOA16r

[CarlottaB @CarlottaB]

🗺️ Follow the roadmap to consensus on the integration of radiation therapy with new systemic treatments in head & neck cancer https://t.co/Scm85erlp1
📍 Looking forward to the Consensus in Florence, 9–10 October 2026
🤝 Let’s continue the discussion!
#oncoAlert #Oncology

[Marianna Valzano @MariValzano]

📢Registration is open for #FlorenceConsensus26.

Join leading experts in Florence, 9–10 Oct 2026, for a Multidisciplinary Consensus on the integration of radiotherapy with new systemic treatments.

⏰Free registration | 100 places available.
@OncoAlert

[Icro Meattini @Icro_Meattini]

🚨 Registration OPEN! https://t.co/VXlTIzC48a

Join the 2nd International Multidisciplinary Consensus on the Integration of RT with Systemic Treatments #FlorenceConsensus26

Florence 🇮🇹 9–10 Oct 2026
✅ FREE registration ⚠️ 100 spots – first come, first served! @OncoAlert

[Icro Meattini @Icro_Meattini]

SBRT plus abiraterone and ADT versus abiraterone and ADT in oligometastatic castrate-resistant #prostatecancer (ARTO): long-term OS of an open-label, randomised, phase 2 trial

Bravo Giulio Francolini💪🏼 @GiulioFrancoli1

https://t.co/rbn5SaQV0h

#OncoAlert @OncoAlert

[Dr. Nina Niu Sanford @NiuSanford]

Impressive daraxonrasib data.

From RT standpt, if RAS inhibition meaningfully prolongs dz control, local progression = more relevant

Future trials should test consolidative ablative RT in pts responding to darax (potentially leveraging RAS-mediated radiosens) #ASCO26 @OncoAlert

[Azienda Ospedaliero-Universitaria Careggi @AOUCareggi]

🌍 ESTRO 2026: i professionisti della Radioterapia di Careggi protagonisti a Stoccolma

[youngAIRO @airo_young]

Ieri, presso la Camera dei Deputati, durante la II edizione degli Stati Generali della Radioterapia Oncologica promossa da #AIRO, il confronto si è concentrato su formazione, innovazione e futuro!
Come #AIROGiovani, abbiamo partecipato attivamente! #RadOncs4Life

[Marianna Valzano @MariValzano]

❤️

[Icro Meattini @Icro_Meattini]

The University of Florence crew #ESTRO26

🤍🤍🤍💪🏼💪🏼💪🏼

[Icro Meattini @Icro_Meattini]

Thrilled to share our work: #radiotherapy management in BRCA1/2 carriers with early #breastcancer

A big thank you to all collaborators - especially the outstanding team led by @matteolambe for this truly international effort

Link: https://t.co/2DX3X1I1BT

@OncoAlert #OncoAlert